-
2024-518399-29-00
5
2024-12-27
Testicular cancer
-
2023-510422-32-00
5
2024-09-10
Tenosynovial Giant Cell Tumour
-
2023-505000-27-01
4
2023-12-29
newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-type AML
-
2022-502623-22-00
1
2023-09-18
Metastatic castration-resistant prostate cancer
-
2023-509810-13-00
4
2023-05-13
Acute Lymphoblastic Leukemia (ALL)
-
2022-500479-29-00
10
2023-03-28
International Prognostic Scoring System-Revised (IPSS-R) Low - or Inte
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2023-507031-38-00
5
2023-01-09
Severe viral lung infections
-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
-
2022-502030-12-01
1
2022-10-13
Treatment of patients with Hemophilia A who have developed inhibitory
-
2023-505766-28-00
10
2022-10-10
Hereditary angioedema
-
2022-501374-19-00
4
2022-09-16
Aggressive and Indolent B-cell Malignancies (mantle cell lymphoma; chr
-
2023-505877-34-00
6
2020-08-18
Diffuse cutaneous systemic sclerosis according to the ACR/EULAR criter
-
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2025-524022-18-00
4
2026-05-22
Multiple myeloma
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2025-521416-19-00
4
2026-03-12
Recurrence of Clostridioides difficile Infection
-
2024-519829-38-00
5
2026-01-09
Heart failure due to systemic left ventricular systolic dysfunction
-
2025-521686-27-01
4
2026-01-08
Major Depression
-
2024-515172-12-00
4
2025-12-23
Epidermolysis Bullosa
-
2025-521391-58-00
4
2025-11-28
Asthma
-
2023-503447-33-00
4
2025-11-13
febrile Urinary Tract Infection (fUTI)
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept